000 01553 a2200409 4500
005 20250515214235.0
264 0 _c20100812
008 201008s 0 0 eng d
022 _a1464-3405
024 7 _a10.1016/j.bmcl.2010.02.082
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBursavich, Matthew G
245 0 0 _aNovel benzofuran-3-one indole inhibitors of PI3 kinase-alpha and the mammalian target of rapamycin: hit to lead studies.
_h[electronic resource]
260 _bBioorganic & medicinal chemistry letters
_cApr 2010
300 _a2586-90 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aBenzofurans
_xchemistry
650 0 4 _aCell Line, Tumor
650 0 4 _aHumans
650 0 4 _aIntracellular Signaling Peptides and Proteins
_xantagonists & inhibitors
650 0 4 _aModels, Molecular
650 0 4 _aPhosphoinositide-3 Kinase Inhibitors
650 0 4 _aProtein Kinase Inhibitors
_xchemistry
650 0 4 _aProtein Serine-Threonine Kinases
_xantagonists & inhibitors
650 0 4 _aStructure-Activity Relationship
650 0 4 _aTOR Serine-Threonine Kinases
700 1 _aBrooijmans, Natasja
700 1 _aFeldberg, Lawrence
700 1 _aHollander, Irwin
700 1 _aKim, Stephen
700 1 _aLombardi, Sabrina
700 1 _aPark, Kaapjoo
700 1 _aMallon, Robert
700 1 _aGilbert, Adam M
773 0 _tBioorganic & medicinal chemistry letters
_gvol. 20
_gno. 8
_gp. 2586-90
856 4 0 _uhttps://doi.org/10.1016/j.bmcl.2010.02.082
_zAvailable from publisher's website
999 _c19666875
_d19666875